Please login to the form below

Not currently logged in
Email:
Password:

NDA

This page shows the latest NDA news and features for those working in and with pharma, biotech and healthcare.

Ipsen’s Sohonos approved by Health Canada

Ipsen’s Sohonos approved by Health Canada

Ipsen had previously announced the withdrawal of its New Drug Application (NDA) to the US Food and Drug Administration (FDA) for palovarotene in August 2021. ... It was agreed by Ipsen and the FDA that the completion of the process would not be possible

Latest news

More from news
Approximately 0 fully matching, plus 152 partially matching documents found.

Latest Intelligence

  • China’s clinical trial shake-up China’s clinical trial shake-up

    China indicated it would no longer tolerate inauthentic or incomplete clinical data when it asked companies with pending new drug applications (NDAs) to self-assess their submissions. ... When faced with the threat of punishment if they proceeded with

  • Chinese biotech’s global ambitions Chinese biotech’s global ambitions

    BeiGene is preparing to submit in the first half of 2019 a New Drug Application (NDA) to pursue an accelerated approval of zanubrutinib for WM patients.

  • Significant figures Significant figures

    a company right now is our NDA filing of ALIS in the US.”. ... Olaf said that ALIS’ second NDA filing will most likely be in Japan due to its big NTM population and the regular frequency of physicians testing for NTM disease in patients.

  • Licensing

  • Drug safety

More from intelligence
Approximately 0 fully matching, plus 22 partially matching documents found.

Latest appointments

  • Claes Buxfeldt joins NDA Claes Buxfeldt joins NDA

    He becomes its new HTA director. AstraZeneca’s former global price and reimbursement director Claes Buxfeldt has joined the NDA advisory board. ... Buxfeldt’s new role at NDA will see him drive and develop the group’s service offerings in the HTA

  • NDA Group appoints Alison McGregor as its principal consultant NDA Group appoints Alison McGregor as its principal consultant

    She joins the group following a new US office launch. Drug development consultancy, NDA Group, has appointed Alison McGregor as its principal consultant following the opening of its new US office ... Johan Stromquist, chief executive officer, NDA Group,

  • Dr Paula Salmikangas joins NDA Group Dr Paula Salmikangas joins NDA Group

    UK-headquartered regulatory affairs consultancy the NDA Group has appointed Dr Paula Salmikangas as a director. ... Dr Werner Van den Eynde, VP of NDA’s Advisory Board, said: “I am very excited to welcome Dr Paula Salmikangas on board.

  • NDA Group appoints new vice president NDA Group appoints new vice president

    Regulatory affairs consultancy group NDA has appointed Dr Werner Van den Eynde as its new vice president to head up its advisory board providing strategic advice to pharmaceutical clients during its ... His new role will see him manage strategy

  • NDA bolsters its senior team NDA bolsters its senior team

    Hires Eva Lilienberg, Christine Chirdo and Barbara Clendenen. Drug development consultancy NDA Group has expanding its service offerings and geographic reach with the addition of three new hires. ... Additionally, Christine Chirdo also joins the team as

More from appointments
Approximately 7 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • 5 Reasons To Add Character Animation To Your Next Campaign. 5 Reasons To Add Character Animation To Your Next Campaign.

    Working primarily in Healthcare, the vast majority of our work is covered by NDAs, so you may never know what else we offer.

  • The Good Ideas Group The Good Ideas Group

    NHS, COMPASS Pathways, Unilabs, Allergan and many more under NDA.

  • Weinberg Group

    The Weinberg Group is the global leader in regulatory and compliance services. We have provided biotech, medical device and pharmaceutical consulting services for over 30 years.

  • NDA

    NDA is Europe’s leading regulatory affairs consultancy, providing clients with a unique insight into EU regulatory thinking and the best possible expert guidance and support to optimise the time to ... Year on year, NDA has contributed towards more

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....